NCT04687930

Genicular Nerve Block in Juvenile Idiopathic Arthritis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 104 (actual)
• Sponsor: Sohag University · Academic / Other
• Sex: All
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

N=104 juvenile idiopathic arthritis patients diagnosed after ILAR criteria with unilateral persistent knee arthritis. They will be randomly assigned into two groups; group 1 will receive genicular nerve block, group 2 intra-articular triamcinolone. Both groups will be examined by SOLAR ultrasound scoring system, Visual analogue scale and Lysholm score at 0, 2 and 12 weeks. A semi-quantitative score will be used to assess tenderness and swelling at the same intervals.

Conditions

• Juvenile Idiopathic Arthritis
• Persistent Knee Arthritis
• no Intra-articular Injection in the Last 3 Months
• no Other Cause for Chronic Kneearthritis

Interventions

Type	Name	Description
DRUG	genicular nerve block	nerve block of the genicular nerve at 3 points around the inflamed knee using ultrasound.
DRUG	intra-articular steroid injection	Triamcinilone injection into the knee joint under ultrasound guidance.

Timeline

• Start date: 2020-12-01
• Primary completion: 2021-02-15
• Completion: 2021-02-15
• First posted: 2020-12-29
• Last updated: 2021-07-23

Locations

1 site across 1 country: Egypt